This study was performed to obtain information on the enzymatic background to the antiviral activity of acyclic guanosine analogs. Five acycic guanosine analogs, the (R)-and (S)-enantiomers of 9-(3,4-dihydroxybutyl)guanine, 9-(4-hydroxybutyl)guanine, 9-[(2-hydroxyethoxy)methyl]guanine, and 9-[[2-hydroxy-1-(hydroxymethyl)ethoxy]methyl]guanine, were compared in enzyme kinetic experiments using purified varicella-zoster virus and human placenta mitochondrial thymidine kinase (TK). All analogs showed competitive patterns of inhibition in the phosphorylation of thymidine by varicella-zoster virus TK, but only low affinities and phosphorylation rates were observed. No affinity for the mitochondrial TK was observed for any of the analogs.
Herpes simplex virus type 1 (HSV-1), HSV-2, and varicella-zoster virus (VZV) induce a virus-specific thymidine kinase (TK) (18) . These TKs differ in biochemical, immunological, and substrate specificities compared with the corresponding cellular TKs (18) . These differences in substrate specificity have been used in efforts to find potent and selective inhibitors of HSV-1 and HSV-2. The selective antiviral action of most nucleoside analogs depends on two factors: a preferable first phosphorylation by viral rather than cellular TKs and a selective interaction of the corresponding triphosphates on viral DNA polymerization (7) . The nucleoside analogs can be divided into two different structure classes, the 5-substituted 2'-deoxypyrimidines (5) and the acyclic guanosine analogs (9, 17, 22, 23, 26) . In general, nucleoside analogs corresponding to the first group show high affinity for and function as good substrates for the viral TK [exemplified by (E)-5-(2-bromovinyl)-2'-deoxyuridine (BVDU) ; 3] . Nucleoside analogs from the second group exhibit low affinity for the viral TK and are poorer substrates (exemplified by 9-[(2-hydroxyethoxy)methyl]guanine [ACV; 12, 22, 24] ). During the past few years, new acyclic guanosine analogs have been developed which have been shown to be better substrates for the HSV-1 and HSV-2 TKs than ACV. 9-(3,4-Dihydroxybutyl)guanine (DHBG) (23, 24) and 9-(4-hydroxybutyl)guanine (HBG) are especially suitable as substrates (17, 22, 24) , but even 9-[[2-hydroxy-1-(hydroxymethyl)ethoxy]methyl]guanine (Biolf-62, DHPG, and 2'NDG) is relatively well accepted (1, 10, 26) . The VZV TK has been less studied than the HSV-1 and HSV-2 TK concerning its interaction with nucleoside analogs.
The aim of this study was to compare several acyclic guanosine analogs as substrates for VZV-induced and human mitochondrial TK and furthermore to investigate whether there is any correlation with reference to the suitability of the analogs as substrates for the viral TK and how effectively they restrict VZV multiplication in cell culture.
The synthesis of (R)-and (S)-DHBG (manuscript in preparation) and HBG (22) (4, 13, 19) , and the molecular sizes, as determined by analytical gradient polyacrylamide gel electrophoresis (4 to 30%), were approximately 86,000 and 69,000 daltons (13, 19, 20) for VZV and mitochondrial TKs, respectively.
The kinetic studies were performed with 1 U of enzyme (the amount of enzyme needed to catalyze the formation of 1 pmol of dTMP per min at 37°C). Samples were taken at 4-min intervals for 20 min. The final concentrations of the components in the assay system were previously reported (15) . To obtain Km and Vsat values, the experimental data were analyzed by using a computer program based on the method of Hanes for the analysis of enzyme kinetics. The K, values for the tested compounds were determined from double-reciprocal plots as described by Lineweaver and Burk, using the relationship for competitive inhibitors that slope I = (slope 0) x (1 + [I]lKi) (slope I = slope for inhibited reaction, slope 0 = slope for uninhibited reaction, and [I] = inhibitor concentration). To determine the suitability of the test compounds as substrates for the TKs, we applied the procedure of Dobersen and Greer (8) Inhibition of dThd phosphorylation by nucleoside analogs with purified VZV TK. Reaction rates were determined at different concentrations of dThd and two or three concentrations of the analogs. The assay conditions were as described in the text, and the nucleoside concentrations were as described in the figure. (A) (R)-DHBG; (B) HBG; (C) ACV; (D) BVDU. cells was determined by measuring the effect of the various analogs on viral protein production by enzyme-linked immunosorbent assay as previously described (27, 28) .
As shown in the double-reciprocal plot in Fig. 1 (Table 1) show that all the analogs tested had a low affinity for the VZV TK. The lowest K;, the best affinity, was observed for HBG at 337 ,uM, whereas the Kis for (R)-DHBG, (S)-DHBG, ACV, and Biolf-62 were as low as 732, 567, 858, and 1,369 ,uM, respectively. As a comparison, the 5-substituted 2'-deoxyuridine analog, BVDU, was included in the experiments (Fig. 1D) , and a high affinity, with a Ki of 0.14 ,uM, was observed for this analog. None of the listed acyclic guanosine analogs showed drug affinity for the mitochondrial TK (Ki >1,000 ,uM), but once again, BVDU differed from these analogs, and a K; of 0.55 ,uM was observed. The determination of the relative rate of phosphorylation compared with that of dThd showed that among the acyclic analogs tested, the (R) form of DHBG was phosphorylated to the highest degree, about 20%, whereas the other analogs were phosphorylated to about 10%. BVDU seemed to be phosphorylated to 35% compared with dThd, a result which differed from data published by Fyfe (11) , but this could have been due to the fact that a different VZV strain was used for these investigations (16) .
Examination of the effect of the acyclic guanosine analogs on VZV multiplicaton in cell culture as determined by the enzyme-linked-immunosorbent assay technique showed that the most potent inhibitors of replication were Biolf-62 and ACV which inhibited viral protein production 50% at concentrations of 4.5 and 6.5 ,uM, respectively (ID50; Table 1 ). The (R)-enantiomer of DHBG was more inhibitory than the (S)-enantiomer, with ID5os of 25 and 363 ,uM, respectively. BVDU was a more potent inhibitor than any of the acyclic guanosine analogs tested, and an ID50 of 0.55 ,uM was observed for the VZV strain tested.
The acyclic guanosine analogs evaluated in this study were previously shown to be good inhibitors of HSV-1 and HSV-2 multiplication in cell cultures and to require virusinduced TK for antiviral activity (1, (22) (23) (24) . Furthermore, all analogs have been shown to be substrates for HSV-1 and HSV-2 TK, but they were seen to have different affinities and phosphorylation rates (1, 10, 12, (22) (23) (24) . (R)-and (S)-DHBG and HBG were shown to have a particularly high affinity for HSV-1 and HSV-2 TK (1.5 and 2.1 ,uM, respectively) (22-24) compared with ACV(173 ,uM) (22) but even in comparison to Biolf-62 (13 ,uM for the HSV-1 TK) (1; A. Larsson, unpublished data).
In the present study, all tested analogs were competitive for the phosphorylation of dThd by purified VZV TK. However, none of the acyclic guanosine analogs evaluated were good substrates for VZV TK (Table 1) , a result which differed from what earlier had been shown for the HSV-1 or HSV-2 TK (1, 22-24 ). The smallest difference was observed for ACV, which also showed low affinity to HSV-1 and HSV-2 TK.
No strict correlation was found between the ability of the acyclic guanosine analogs to act as substrates for VZV TK and their capacity to inhibit VZV multiplication in cell culture (Table 1) . ACV and Biolf-62, which were the poorest substrates for the VZV TK, were the most potent inhibitors of VZV multiplication ( Table 1) . Evaluation of the effects of the corresponding triphosphates on the VZV DNA polymerase and the amount of triphosphates formed in the VZVinfected cells will be required to understand the comparatively good effect against VZV multiplication in cell culture of these analogs. However, when the ability to act as substrate for HSV-1, HSV-2, and VZV TK was compared with the effect on viral multiplication for each of the analogs, a correlation was observed. In general, those analogs that were the best substrates for HSV-1 TK were also the most potent inhibitors of HISV-1 replication in cell culture. When lower affinity for HSV-2 TK and, especially, for VZV TK was observed, it followed that the ability to inhibit HSV-2 and VZV multiplication also decreased (22) (23) (24) .
None of the acyclic guanosine analogs studied had affinity for the human mitochondrial TK (Table 1) , as has previously been found for the cellular cytosol TK (22) (23) (24) . This differed, however, in the case of BVDU, which was a good substrate for both the VZV and mitochondrial TK. The K, values obtained were similar to those obtained earlier (3) .
Due to the lack of affinity for cellular cytosol TK of these acyclic analogs, we speculate that the combination of a guanine base and an acyclic carbon chain is more likely to simulate deoxycytidine (dCyd) than dThd in the interaction with the active site on the viral TK. Although a great variability in Km for dCyd has been found by different investigators using more or less purified enzyme preparations, the general trend shows a higher K,n for VZV than HSV-1 TK (2, 4). When purified enzymes were investigated by the same researchers, the following Km values were found for dCyd: HSV-1 TK, 25 ,uM; HSV-2, 88 F.M; and 180 p.M for VZV TK; the Km values obtained for dThd were about the same for these kinases, 0.5 puM (2, 4). When the various affinities to these kinases were compared, it was possible to make a correlation between the decreasing affinity observed for dCyd and that of the guanosine analogs. Furthermore, an HSV-1 TK mutant against ACV with decreased sensitivity for ACV and dCyd but with unchanged sensitivity for dThd, compared with that of the wild strain, has been found (21) . It has also been shown that, in the case of HSV-1, dThd and dCyd compete with each other, showing that these molecules bind to the same site on the enzyme (14) or, at least, to overlapping sites.
Other herpesviruses, like pseudorabies virus and infectious bovine rhinotracheitis virus, induce a TK enzyme which is not able to use dCyd as a substrate (29) , and hence these viruses are not inhibited by ACV, (R)-DHBG, or HBG suggested that in the case of these viruses the antiviral activity of BVDIJ requires phosphorylation on the dThd site of the enzyme, whereas the virus-coded dCyd kinase site of the TK is essential for phosphorylation of the acyclic guanosine analogs (6) .
In summary, the guanosine analogs evaluated in this study were poorer substrates for VZV TK than has been reported for HSV-1 and HSV-2 TK, and the mitochondrial TK, as was shown esrlier for cytosol TK (22) (23) (24) , also lacked the ability to phosphorylate these analogs.
